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Background: Familial Mediterranean fever (FMF) is an inflammatory disease, which is suggested to be associated
with increased risk of atherosclerosis. Epicardial adipose tissue (EAT) thickness and the mean platelet volume (MPV)
are parameters used in prediction of atherosclerotic risk in various conditions. These parameters were evaluated in
children with FMF and compared with healthy controls.
Methods: Forty-five patients with FMF and 54 age- and gender-matched healthy controls were assessed. Duration
of symptoms, age at diagnosis, duration of delay in diagnosis, frequency and duration of FMF attacks, disease
severity scores, response to colchicine therapy, MEditerraneanFeVer (MEFV) gene mutations, and MPV values were
recorded. EAT thicknesses were measured by echocardiography.
Results: Epicardial adipose tissue thicknesses of the children with FMF were found to be significantly greater than
that of controls (5.1 ± 1.4 vs. 4.5 ± 0.9 mm, p = 0.036). FMF patients had significantly higher MPV values compared
with the controls (7.8 ± 1.1 vs. 7.3 ± 1.4 fl, p = 0.044). Age at diagnosis, duration of delay in diagnosis, and MPV
values were found to be correlated with EAT thickness in the patient group (r = 0.49, p = 0.001 for the former
parameters and r = 0.32, p = 0.04 for MPV).
Conclusion: Epicardial adipose tissue thickness and MPV values seem to be increased in children with FMF. These
findings may indicate an increased risk of atherosclerosis in FMF patients.
Keywords: Familial Mediterranean fever, Epicardial adipose tissue thickness, Mean platelet volume, Atherosclerosis,
InflammationIntroduction
Familial Mediterranean fever (FMF) is the most common
cause of hereditary recurrent fever. It is an auto-
inflammatory disease, characterized by attacks of fever,
abdominal pain, chest pain, arthritis, and skin rashes.
Familial Mediterranean fever is common in people from
Eastern Mediterranean region, especially in Sephardic
Jewish, Armenian, Turkish, and Arabic population [1,2].
Systemic inflammation plays an important role in de-
velopment and progression of atherosclerosis. The possi-
bility of atherosclerosis was reported to be increased in
cases with rheumatic diseases [1,3]. Case-control studies* Correspondence: ulucaunal@hotmail.com
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and endothelial dysfunction found a predisposition of
FMF patients to atherosclerosis [4,5]. Mean platelet vol-
ume (MPV) and epicardial adipose tissue (EAT) thick-
ness are novel parameters used in prediction of the risk
of atherosclerosis [3,6-8]. Albeit contradictory results
have been reported, there are some studies investigating
the usefulness of MPV in assessment of atherosclerotic
risk in cases with FMF [6,9,10]. However, no study
evaluating EAT thicknesses of FMF patients was re-
ported so far.
In this study, we investigated whether EAT thickness
and MPV values differ in cases with FMF, when com-
pared with healthy controls and assessed the correlation
between EAT and MPV.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Study population
Forty-five FMF patients diagnosed according to Tel-
Hashomer criteria [11] and age- and gender-matched 54
healthy normal weighted controls were enrolled into the
study. Patients who experienced an FMF attack within
two weeks prior to admission, overweighed children, and
cases with dyslipidemia or any coexistent inflammatory
disease were excluded from the study. The study proto-
col was approved by the Dicle University Hospital Ethics
Committee.
Data regarding age, gender, weight, height, body mass
index (BMI) which was calculated as weight/(height)2
(kg/m2), and MPV values of the patients and controls
were detected and recorded. Duration of symptoms, age
at diagnosis, duration of delay in diagnosis, frequency
and duration of FMF attacks, response to colchicine, and
determined MEditerraneanFeVer (MEFV) gene muta-
tions in FMF patients were recorded. The severity of dis-
ease was determined according to the criteria adapted
by Ozen et al. [12] for affected children. Scores ranging
from 3 to 5 points indicated mild disease, between 6 and
9 points showed moderate disease, and greater than 9
points was considered as severe disease.Measurement of epicardial adipose tissue thickness
All transthoracic echocardiographic examinations were
performed by an experienced pediatric cardiologist (F.D.).
A Vivid 5 Ultrasound System with appropriate trans-
ducers (GE Medical Systems, Horten, Norway) was
used for echocardiographic evaluations. The epicardial
adipose tissue was seen as an echo-free space between
the outer surface of myocardium and visceral pericar-
dium on two-dimensional echocardiography, and its
thickness was measured on the free wall of right ven-
tricle at end-diastole in parasternal long-axis view [13].Table 1 The main characteristics of the patients and the
control group
FMF group Control group p
(n = 45) (n = 54)
Gender (M/F) 19 / 26 24 / 30 NS
Age (years) 8.1 ± 4.1 7.9 ± 4.6 NS
BMI (kg/m2) 16.2 ± 2.3 16.3 ± 3.4 NS
EAT thickness (mm) 5.1 ± 1.4 4.5 ± 0.9 0.036
MPV (fl) 7.8 ± 1.1 7.3 ± 1.4 0.044
Onset of symptoms (years) 4.1 ± 3.0
Age of diagnosis (years) 5.8 ± 3.0
Delay in diagnosis (years) 1.7 ± 1.9
BMI: Body mass index, EAT: Epicardial adipose tissue, FMF: Familial Mediterranean
fever, F: Female, M: Male, MPV: Mean platelet volume, NS: Not significant.Statistical analysis
The data were processed with SPSS (Statistical Pack-
age for Social Sciences) 16.0 program for Windows.
Kolmogorov-Smirnov test was used to determine the
distribution pattern of data. Normally distributed numer-
ical variables were shown as mean ± standard deviation.
Because of normal distribution, numeric variables of the
patients and controls were compared with Student T-test.
Kruskal-Wallis test was used for the comparison of three
mutation-based patient subgroups. Chi-square test was
used to compare categorical variables between the study
groups. Correlations between numerical variables were
evaluated by Pearson’s or Spearman’s correlation analysis.
A p value less than 0.05 was accepted as statistically
significant.Results
The study included 45 children with FMF (19 male, 26 fe-
male) and 54 healthy matched controls (24 male, 30 fe-
male). The main characteristics of the patient and the
control groups are summarized in Table 1. The mean epi-
cardial adipose tissue thicknesses of the patient and the
control groups were 5.1 ± 1.4 and 4.5 ± 0.9 mm, respect-
ively and the mean EAT thickness of the children with
FMF were found significantly higher than that of controls
(p = 0.036). FMF patients had significantly higher MPV
values compared with the controls as well (7.8 ± 1.1 vs.
7.3 ± 1.4 fl, p = 0.044). There were no significant differ-
ences between the groups in terms of gender, age, or BMI
(p > 0.05, for each comparisons). Age at diagnosis, dur-
ation of delay in diagnosis, and MPV values were found to
be correlated with EAT thickness in the patient group
(r = 0.49, p = 0.001 for the former parameters and r =
0.32, p = 0.04 for MPV). However, no correlation was
found between disease severity score and EAT thickness.
Forty-two of 45 FMF patients (93.3%) had a MEFV gene
mutation. The patients were divided into three subgroups
according to MEFV mutations (homozygote, heterozygote,
and compound heterozygote) and the comparison of those
subgroups in terms of EAT thickness and MPV revealed
no significant difference (p > 0.05). Nine (21.4%) patients
had M694V mutation and 33 (78.6%) patients with muta-
tions other than M694V mutation such as V726A, M680I
or R761H etc. Although, M694V mutation group had in-
creased EAT (5.84 ± 1.94 vs. 4.79 ± 1.31 mm) and MPV
(7.90 ± 0.96 vs. 7.73 ± 1.10 fl) values, while compared with
the other MEFV mutations’ group, these differences did
not reach to statistically significant levels (p = 0.107 and
p = 0.497, respectively).
Discussion
Systemic inflammation is an important risk factor for ath-
erosclerosis. Carotid intima media thickness, endothelial
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ters that suggested for evaluation of increased atheroscler-
otic risk [3-5,7]. Familial Mediterranean fever is an
inflammatory disease suggested to predispose to athero-
sclerosis [4-6]. The current study has found that FMF
cases had significantly higher EAT thicknesses and MPV
values when compared to healthy controls and EAT thick-
ness has correlated with age of diagnosis, duration of delay
in diagnosis, and MPV values.
Epicardial adipose tissue is a structure surrounding
myocardium. It is composed mainly of adipocytes, but
inflammatory, stromal, vascular, and nerve cells may also
exist [14]. Epicardial adipose tissue expresses and se-
cretes several bioactive molecules including interleukin
(IL)-1, IL-1β, IL-6, IL-8, and IL-10, the levels of these in-
terleukins were found as significantly higher in subjects
with coronary artery disease when compared to healthy
subjects [15]. Additionally, it was found that epicardial
adipose tissue produces higher levels of inflammatory
cytokines and reactive oxygen species than subcutaneous
fat tissue in cases with coronary artery disease [16]. Re-
cently, a meta-analysis of 16 studies revealed a correl-
ation between EAT thickness and coronary artery
disease [17]. Increased EAT volume was reported to be a
stronger coronary risk factor than increased fat volume
in any other part of the body. This may be related to
proximity of EAT to coronary arteries. Possibly because
of above-mentioned chronic low-grade inflammation
and endothelial injury associated with reactive oxygen
species, increased EAT seems to play important roles in
pathogenesis of atherosclerosis.
Platelet activation has been suggested as a triggering
factor in development of atherosclerosis and the mean
platelet volume is accepted as a good indicator of plate-
let activation. CXCL4 is a chemokine of platelets having
atherogenic activities by altering differentiation of T cells
and macrophages, inhibiting apoptosis of neutrophils
and monocytes, and stimulating CCL5. CCL5 is depos-
ited on vascular endothelium and triggers atherogenic
activities of monocytes. Platelet surface molecules such
as GPIIb/IIIa, GP1bα, and P-selectin interact with endo-
thelial cells, leukocytes and matrix components, which
resultantly affect atherogenesis. Besides these, platelets
also contribute to formation of lipid laden macrophages
by modifying and endocytosing LDL particles [18,19].
Familial Mediterranean fever is an IL-1β dependent
auto-inflammatory disease and is related to dysregula-
tion of nod-like receptor family pyrin domain-containing
3 inflammasome (NLRP3) [20]. IL-6 and TNF-α levels
were found higher in patients with FMF during both at-
tack and attack-free period [21]. As mentioned above,
inflammation is an important risk factor for atheroscler-
osis and EAT secretes various cytokines including IL-1β,
IL-6, and TNF-α, the levels of which were significantlyhigher in patients with coronary artery disease [15]. The
cause of increased EAT thickness in FMF cases remains
unexplained. However, similarity in cytokine profiles of
EAT and FMF disease makes us think that, these cyto-
kines may have some roles in thickening of EAT and
FMF. FMF may be associated with increased atheroscler-
otic risk through the cytokines released by thickened
EAT and/or by inflammatory cells functioning in the
pathogenesis of FMF. Platelet activation indicated by in-
creased MPV values in our patients may also contribute
to this atherosclerotic risk.
Mean platelet volume and EAT thickness are sug-
gested to be used in prediction of the risk of atheroscler-
osis in various conditions including psoriatic arthritis,
Behçet’s disease, ankylosing spondylitis, etc. [7,8,22].
Studies evaluating carotid intima media thickness and
endothelial dysfunction in FMF patients have found an
increased risk of atherosclerosis [4,5]. Usefulness of
MPV in assessment of atherosclerotic risk in cases with
FMF was also investigated. In accordance with our re-
sults, most of the studies found significantly higher
MPV values in FMF patients and stated that FMF is as-
sociated with increased risk of atherosclerosis [6,9,10].
MPV values were found higher even in attack-free FMF
cases. However, some other investigators did not deter-
mine any increase in platelet volumes [23,24]. Only one
research reported lower MPV values in cases having
FMF [25]. No study evaluated the atherosclerotic risk of
FMF patients through measurement of EAT thickness so
far. Atherosclerotic risk resulted from FMF-related
chronic inflammation may be further increased by EAT
thickness and MPV. We think the current investigation
is unique because of simultaneous assessment of MPV
values and EAT thicknesses in children with FMF. The
finding that both of the parameters indicating athero-
sclerotic risk were increased in FMF patients may be as-
sociated with higher probability of atherogenesis. In
previous studies, M694V mutation has been found to-
gether with severe disease and more frequent renal
amyloidosis development in patients with FMF [2,12]. In
our study, despite increased mean values of both EAT
and MPV in M694V mutation group in comparison with
other MEFV mutations’ group, these differences did not
reach to significant levels, probably because of small
number (n = 9) of patients in M694V subgroup. Further-
more, the mean age of our study group was 8.1 years;
therefore these non-significant differences can reach to
significant levels with increasing age especially for EAT.
Further studies with more patients are needed to clarify
this point.
Determination of increased risk of atherosclerosis in
FMF patients even in childhood is important. MPV is a
cheap and easily available parameter. Echocardiography
provides simple and noninvasive assessment of EAT
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years; such an atherosclerotic risk may be associated
with significant morbidity or mortality. Increased aware-
ness about this risk may provide to take some measures
for prevention of potential morbidities.
There are some limitations of the present study to be
mentioned. The main limitation of the study is that pa-
rameters suggested to be related with atherosclerosis
were evaluated cross-sectionally and follow-up measure-
ments were not obtained. Relatively small sample size is
the other limitation.
In conclusion, epicardial adipose tissue thickness and
MPV values seem to be increased in children with FMF.
We think EAT thickness and MPV are useful variables
indicating the risk of atherosclerosis and may be evalu-
ated in FMF patients of all ages. These findings may ne-
cessitate close follow-up and taking proper preventive
measures.
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